KKK123的个人主页 - 老虎社区

KKK123

KKK123

暂无个人介绍

IP属地：未知

15关注

1粉丝

0主题

0勋章

2021-08-05

Good

Qualcomm tops Magna's bid with $4.6 billion offer for Veoneer

2021-07-01

Be careful

This Hot Reddit Stock Just Gave Investors an Ominous Warning

2021-07-01

May be

抱歉，原内容已删除

2021-07-01

Ok

3 Unstoppable Stocks to Buy and Hold for Years

2021-06-30

Ok

抱歉，原内容已删除

2021-06-30

Ok

抱歉，原内容已删除

2021-06-30

Nice

抱歉，原内容已删除

2021-06-30

Nice

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4088084941946900","uuid":"4088084941946900","gmtCreate":1624982278796,"gmtModify":1625110472823,"name":"KKK123","pinyin":"kkk123","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":15,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":899638695,"gmtCreate":1628177069617,"gmtModify":1633752878078,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899638695","repostId":"2157430168","repostType":4,"repost":{"id":"2157430168","kind":"news","pubTimestamp":1628173962,"share":"https://ttm.financial/m/news/2157430168?lang=&edition=full","pubTime":"2021-08-05 22:32","market":"us","language":"en","title":"Qualcomm tops Magna's bid with $4.6 billion offer for Veoneer","url":"https://stock-news.laohu8.com/highlight/detail?id=2157430168","media":"Reuters","summary":"(Reuters) -Chipmaker Qualcomm Inc said on Thursday it had offered to buy Swedish auto parts maker Ve","content":"<p>(Reuters) -Chipmaker Qualcomm Inc said on Thursday it had offered to buy Swedish auto parts maker Veoneer Inc for $4.6 billion, an 18.4% premium to a bid by Canada's Magna International Inc that was accepted by Veoneer's board.</p>\n<p>U.S.-listed shares of Veoneer rose 21.7% in premarket trading as the stage was set for a bidding war. Neither Magna or Veoneer made any immediate comment.</p>\n<p>Demand has been on the rise for advanced driver assistance systems, known in the industry as ADAS, that add features ranging from collision warning to parking assist. Some systems collect data from cameras and radar to monitor surroundings, interpret the situation and take action.</p>\n<p>Qualcomm, apart from powering mobile phones, has been a chip supplier to carmakers for a decade and last year started its own line of ADAS systems called Snapdragon Ride.</p>\n<p>Earlier this year it signed a signed a collaboration deal with Veoneer to develop a software and chip platform for driver-assistance systems.</p>\n<p>While fully self-driving vehicles are years away, assisted-driving features, such as adaptive cruise control, are being fitted into new cars by most manufacturers.</p>\n<p>Qualcomm hopes to grow its automotive chips business by creating open and competitive platforms for automakers along with Veoneer.</p>\n<p>\"As the automotive industry continues to transform, it is becoming increasingly important for automakers to have a partner who develops horizontal platforms that drive innovation and enable competition,\" said Qualcomm CEO Cristiano Amon.</p>\n<p>Magna has a similar interest in buying Veoneer as it tries to compete with ADAS makers such as Aptiv, Bosch and Continental to capture a larger share of the booming business.</p>\n<p>The Canadian company had offered to buy rival Veoneer in July for about $3.8 billion in cash.</p>\n<p>(Reporting by Chavi Mehta in Bengaluru and Supantha Mukherjee in Stockholm; Editing by Krishna Chandra Eluri, Vinay Dwivedi, Elaine Hardcastle)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qualcomm tops Magna's bid with $4.6 billion offer for Veoneer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQualcomm tops Magna's bid with $4.6 billion offer for Veoneer\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-05 22:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/qualcomm-offers-buy-automotive-tech-131242676.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -Chipmaker Qualcomm Inc said on Thursday it had offered to buy Swedish auto parts maker Veoneer Inc for $4.6 billion, an 18.4% premium to a bid by Canada's Magna International Inc that was ...</p>\n\n<a href=\"https://finance.yahoo.com/news/qualcomm-offers-buy-automotive-tech-131242676.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VNE":"Veoneer, Inc.","QCOM":"高通"},"source_url":"https://finance.yahoo.com/news/qualcomm-offers-buy-automotive-tech-131242676.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2157430168","content_text":"(Reuters) -Chipmaker Qualcomm Inc said on Thursday it had offered to buy Swedish auto parts maker Veoneer Inc for $4.6 billion, an 18.4% premium to a bid by Canada's Magna International Inc that was accepted by Veoneer's board.\nU.S.-listed shares of Veoneer rose 21.7% in premarket trading as the stage was set for a bidding war. Neither Magna or Veoneer made any immediate comment.\nDemand has been on the rise for advanced driver assistance systems, known in the industry as ADAS, that add features ranging from collision warning to parking assist. Some systems collect data from cameras and radar to monitor surroundings, interpret the situation and take action.\nQualcomm, apart from powering mobile phones, has been a chip supplier to carmakers for a decade and last year started its own line of ADAS systems called Snapdragon Ride.\nEarlier this year it signed a signed a collaboration deal with Veoneer to develop a software and chip platform for driver-assistance systems.\nWhile fully self-driving vehicles are years away, assisted-driving features, such as adaptive cruise control, are being fitted into new cars by most manufacturers.\nQualcomm hopes to grow its automotive chips business by creating open and competitive platforms for automakers along with Veoneer.\n\"As the automotive industry continues to transform, it is becoming increasingly important for automakers to have a partner who develops horizontal platforms that drive innovation and enable competition,\" said Qualcomm CEO Cristiano Amon.\nMagna has a similar interest in buying Veoneer as it tries to compete with ADAS makers such as Aptiv, Bosch and Continental to capture a larger share of the booming business.\nThe Canadian company had offered to buy rival Veoneer in July for about $3.8 billion in cash.\n(Reporting by Chavi Mehta in Bengaluru and Supantha Mukherjee in Stockholm; Editing by Krishna Chandra Eluri, Vinay Dwivedi, Elaine Hardcastle)","news_type":1,"symbols_score_info":{"QCOM":0.9,"VNE":0.9}},"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151179304,"gmtCreate":1625069133708,"gmtModify":1633945156958,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Be careful","listText":"Be careful","text":"Be careful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151179304","repostId":"2147585034","repostType":4,"repost":{"id":"2147585034","kind":"highlight","pubTimestamp":1625024760,"share":"https://ttm.financial/m/news/2147585034?lang=&edition=full","pubTime":"2021-06-30 11:46","market":"us","language":"en","title":"This Hot Reddit Stock Just Gave Investors an Ominous Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2147585034","media":"Motley Fool","summary":"It's a warning that investors should take seriously.","content":"<p>This year was shaping up to be a miserable <a href=\"https://laohu8.com/S/AONE\">one</a> for&nbsp;<b>Clover Health</b> (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's shares have soared in recent weeks.</p>\n<p>Don't think that the waters are safe to jump aboard the bandwagon for Clover Health yet, however.&nbsp;Here's why this hot Reddit stock just gave investors an ominous warning.</p>\n<h2>Brutal honesty</h2>\n<p>All publicly traded companies want investors to buy their shares. Buying tends to beget more buying, which pushes the stock price up. It's rare that any company warns investors not to buy its stock. But that's exactly what Clover Health did recently.</p>\n<p>Companies that plan to issue additional shares file a prospectus with the U.S. Securities and Exchange Commission (SEC). This prospectus gives potential investors a lot of information about the business and lays out the key reasons why they might want to buy the new shares.</p>\n<p>Clover Health filed such a prospectus earlier this year, outlining its intent to issue additional Class B shares. These shares don't have the same level of voting rights as its Class A shares. Last week, the company submitted an amendment to the SEC for this prospectus. And that amendment contained a brutally honest message for potential investors.</p>\n<p>The company acknowledged that its recent gains could be due to a short squeeze. Because of the potential for an additional short squeeze and its aftermath, Clover Health gave an unusually stark warning to investors: \"Under the circumstances, we caution you against investing in our Class B common stock, unless you are prepared to incur the risk of losing all or a substantial portion of your investment.\" It also noted, \"Investors that purchase shares of our Class A common stock during a short squeeze may lose a significant portion of their investment.\"</p>\n<h2>No fear?</h2>\n<p>Clover Health explained clearly what could happen with both its Class A and Class B shares. The company stated that if another short squeeze happens, once short-sellers cover their positions or if investors otherwise think the short squeeze has run its course, its stock price could fall quickly.</p>\n<p>You might think that such an ominous warning would scare off many investors. Nope. Instead, it produced an opposite effect. Last week, shares of Clover Health soared by a double-digit percentage immediately after the company's amended prospectus with the serious warning was submitted to the SEC.</p>\n<p>This reaction might seem counterintuitive. After all, Clover Health informed investors in no uncertain terms about the risks they face with buying the stock. So why did the shares of the company surge instead of sink? I think there are different reasons for different investors.</p>\n<p>Some truly believe in Clover Health and are willing to hold onto the stock regardless of what happens over the short term. Others are fully aware that the gains generated by a short squeeze could evaporate quickly but think they'll be able to sell in time to still make a big profit. Unfortunately, there could also be some who are new to investing and didn't pay attention to or didn't understand Clover Health's cautionary message.</p>\n<h2>Business vs. stock</h2>\n<p>It's always wise to think of buying a stock as buying a part of a business. That's exactly what you're doing when you buy shares of Clover Health or any other company. When the underlying business is strong and has great prospects, you don't have to be concerned about short-term volatility with the share price.</p>\n<p>However, there are times when share prices get way out of alignment with the prospects of the underlying business. Short squeezes can often make this happen. In these cases, it's especially important to be careful in buying a stock. Sure, you're still buying a part of a business -- but you can pay a lot more than the business is actually worth.</p>\n<p>In my view, there are several reasons to like Clover Health's underlying business. The company has an intriguing technology that physicians use. It's expanding into the original Medicare market, a move that could boost sales tremendously. Clover Health has a visionary management team.</p>\n<p>But buying a stock that's a short squeeze candidate is risky if you aren't ready, willing, and able to sell shares immediately once the short squeeze ends. When a company issues a warning like Clover Health just did, the smart thing to do is to listen and take that warning seriously.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Hot Reddit Stock Just Gave Investors an Ominous Warning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Hot Reddit Stock Just Gave Investors an Ominous Warning\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 11:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This year was shaping up to be a miserable one for Clover Health (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp"},"source_url":"https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147585034","content_text":"This year was shaping up to be a miserable one for Clover Health (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's shares have soared in recent weeks.\nDon't think that the waters are safe to jump aboard the bandwagon for Clover Health yet, however. Here's why this hot Reddit stock just gave investors an ominous warning.\nBrutal honesty\nAll publicly traded companies want investors to buy their shares. Buying tends to beget more buying, which pushes the stock price up. It's rare that any company warns investors not to buy its stock. But that's exactly what Clover Health did recently.\nCompanies that plan to issue additional shares file a prospectus with the U.S. Securities and Exchange Commission (SEC). This prospectus gives potential investors a lot of information about the business and lays out the key reasons why they might want to buy the new shares.\nClover Health filed such a prospectus earlier this year, outlining its intent to issue additional Class B shares. These shares don't have the same level of voting rights as its Class A shares. Last week, the company submitted an amendment to the SEC for this prospectus. And that amendment contained a brutally honest message for potential investors.\nThe company acknowledged that its recent gains could be due to a short squeeze. Because of the potential for an additional short squeeze and its aftermath, Clover Health gave an unusually stark warning to investors: \"Under the circumstances, we caution you against investing in our Class B common stock, unless you are prepared to incur the risk of losing all or a substantial portion of your investment.\" It also noted, \"Investors that purchase shares of our Class A common stock during a short squeeze may lose a significant portion of their investment.\"\nNo fear?\nClover Health explained clearly what could happen with both its Class A and Class B shares. The company stated that if another short squeeze happens, once short-sellers cover their positions or if investors otherwise think the short squeeze has run its course, its stock price could fall quickly.\nYou might think that such an ominous warning would scare off many investors. Nope. Instead, it produced an opposite effect. Last week, shares of Clover Health soared by a double-digit percentage immediately after the company's amended prospectus with the serious warning was submitted to the SEC.\nThis reaction might seem counterintuitive. After all, Clover Health informed investors in no uncertain terms about the risks they face with buying the stock. So why did the shares of the company surge instead of sink? I think there are different reasons for different investors.\nSome truly believe in Clover Health and are willing to hold onto the stock regardless of what happens over the short term. Others are fully aware that the gains generated by a short squeeze could evaporate quickly but think they'll be able to sell in time to still make a big profit. Unfortunately, there could also be some who are new to investing and didn't pay attention to or didn't understand Clover Health's cautionary message.\nBusiness vs. stock\nIt's always wise to think of buying a stock as buying a part of a business. That's exactly what you're doing when you buy shares of Clover Health or any other company. When the underlying business is strong and has great prospects, you don't have to be concerned about short-term volatility with the share price.\nHowever, there are times when share prices get way out of alignment with the prospects of the underlying business. Short squeezes can often make this happen. In these cases, it's especially important to be careful in buying a stock. Sure, you're still buying a part of a business -- but you can pay a lot more than the business is actually worth.\nIn my view, there are several reasons to like Clover Health's underlying business. The company has an intriguing technology that physicians use. It's expanding into the original Medicare market, a move that could boost sales tremendously. Clover Health has a visionary management team.\nBut buying a stock that's a short squeeze candidate is risky if you aren't ready, willing, and able to sell shares immediately once the short squeeze ends. When a company issues a warning like Clover Health just did, the smart thing to do is to listen and take that warning seriously.","news_type":1,"symbols_score_info":{"CLOV":0.9,"JE":0.9}},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151145335,"gmtCreate":1625069025927,"gmtModify":1633945160746,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"May be","listText":"May be","text":"May be","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151145335","repostId":"1153116027","repostType":4,"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151152720,"gmtCreate":1625068859560,"gmtModify":1633945169564,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151152720","repostId":"2147139718","repostType":4,"repost":{"id":"2147139718","kind":"highlight","pubTimestamp":1625060407,"share":"https://ttm.financial/m/news/2147139718?lang=&edition=full","pubTime":"2021-06-30 21:40","market":"us","language":"en","title":"3 Unstoppable Stocks to Buy and Hold for Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2147139718","media":"Motley Fool","summary":"They are in industries where the annual growth rate is 10% or better.","content":"<p>Buying meme stocks or investing in a company due to a pandemic-related trend can be risky. Investors in these companies can face a lot of volatility, especially as consumer preferences or conditions in the economy change.</p>\n<p>A better way to invest for the long term is by identifying trends that are likely going to continue or even intensify in the future. Robotic-assisted surgery, cloud-based technology, and sports betting are examples of sectors that could provide investors with some terrific growth opportunities for several years. And three companies that would give you exposure to those areas are <b>Globus Medical </b>(NYSE:GMED), <b>Microsoft&nbsp;</b>(NASDAQ:MSFT), and&nbsp;<b>DraftKings&nbsp;</b>(NASDAQ:DKNG).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6dfde80107b5c361f54a6ff94e4e926e\" tg-width=\"700\" tg-height=\"393\"><span>Image source: Getty Images</span></p>\n<h2>1. Globus Medical</h2>\n<p>Globus is a medical device company that makes surgical instruments and implantable devices. It also has an ExcelsiusGPS platform, which is a navigational system for robot-assisted surgery. The company says it is \"the world's first revolutionary robotic navigation platform.\" It specifically helps with alignments of the spine.</p>\n<p>The bulk of the company's revenue today comes from its musculoskeletal segment, which relates to its physical devices; in 2020, sales related to that segment totaled $748 million and represented 95% of its revenue. Its enabling technologies segment, which includes ExcelsiusGPS, generated a more modest $40.5 million in sales.</p>\n<p>However, the growth opportunities in this area are too enticing to ignore. Analysts project that the market for robot-assisted surgical systems could be worth nearly $18 billion by 2027, growing at a compounded annual growth rate (CAGR) of 14.8% until then.</p>\n<p>With a solid business today that provides hospitals with important implantable devices&nbsp;<i>plus</i> an exciting growth area related to robotics, Globus can be an investment that provides excellent returns for many years. The healthcare stock has already been picking up steam in the past 12 months, rising more than 70% and outperforming the&nbsp;<b>S&amp;P 500</b>, which is up just 42% during that period.</p>\n<h2>2. Microsoft</h2>\n<p>Tech giant Microsoft is an easy pick for long-term investors. The company provides businesses and individuals with many products and services that will be used for the foreseeable future. Its fastest-growing product is Azure, its cloud computing service where companies can build and test applications. Last quarter, for the first three months of 2021, its year-over-year growth rate was 50% -- highest among the company's segments.</p>\n<p>The cloud computing market is a high-growth sector to invest in, which could be worth more than $832 billion in 2025. It is already more prevalent than robotic-assisted surgery, but it is still growing at a strong CAGR of 17.5%.</p>\n<p>Microsoft also has a stable and growing business that is still generating great numbers. Its Office 365 suite, which includes popular programs like Word, Excel, and PowerPoint, grew its commercial sales by 22% in the most recent quarter. And because Office365 is a recurring service, it should be an excellent source of revenue for the company as businesses and individuals renew their licenses.</p>\n<p>Now that companies are spending more time on the cloud, especially as employees look to continue working remotely, investing in businesses that have many attractive cloud-based products and services like Microsoft is a solid move. Shares of the tech stock are up 37% over the past year, and although they have underperformed the S&amp;P 500, investors shouldn't count on <i>that </i>trend lasting over the long term.</p>\n<h2>3. DraftKings</h2>\n<p>It has been more than three years since the U.S. Supreme Court lifted the federal ban on sports betting. It is a hot new sector to invest in, and it's only getting bigger as more states choose to legalize it.</p>\n<p>Although not everyone has gotten on board with the industry, more than two dozen states now permit some form of sports betting. Globally, the market could be worth $134 billion by 2024 -- growing at a CAGR of close to 10%.</p>\n<p>One company that is in an excellent position to benefit from that is DraftKings. It entered into an exclusive deal with ESPN last year, which will make DraftKings its \"exclusive daily fantasy sports provider.\" While sports activity has been muted during the pandemic, as the economy gets back to normal and sports leagues are back to operating at or near capacity, it could lead to some stellar results for DraftKings this year.</p>\n<p>When the company released its latest results on May 7, it upgraded its guidance and now projects that sales could top $1.15 billion in 2021 (up from a previous forecast that called for no more than $1 billion in revenue). That represents a year-over-year growth rate of 79%.</p>\n<p>Sports betting should only become more popular in the years ahead as more states legalize it, leading DraftKings to deliver fantastic returns to investors. Over the past 12 months, the stock has risen by more than 55%, but that jump shouldn't scare away those with a long-term mindset.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Unstoppable Stocks to Buy and Hold for Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Unstoppable Stocks to Buy and Hold for Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 21:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/30/3-unstoppable-stocks-to-buy-and-hold-for-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Buying meme stocks or investing in a company due to a pandemic-related trend can be risky. Investors in these companies can face a lot of volatility, especially as consumer preferences or conditions ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/30/3-unstoppable-stocks-to-buy-and-hold-for-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/06/30/3-unstoppable-stocks-to-buy-and-hold-for-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147139718","content_text":"Buying meme stocks or investing in a company due to a pandemic-related trend can be risky. Investors in these companies can face a lot of volatility, especially as consumer preferences or conditions in the economy change.\nA better way to invest for the long term is by identifying trends that are likely going to continue or even intensify in the future. Robotic-assisted surgery, cloud-based technology, and sports betting are examples of sectors that could provide investors with some terrific growth opportunities for several years. And three companies that would give you exposure to those areas are Globus Medical (NYSE:GMED), Microsoft (NASDAQ:MSFT), and DraftKings (NASDAQ:DKNG).\nImage source: Getty Images\n1. Globus Medical\nGlobus is a medical device company that makes surgical instruments and implantable devices. It also has an ExcelsiusGPS platform, which is a navigational system for robot-assisted surgery. The company says it is \"the world's first revolutionary robotic navigation platform.\" It specifically helps with alignments of the spine.\nThe bulk of the company's revenue today comes from its musculoskeletal segment, which relates to its physical devices; in 2020, sales related to that segment totaled $748 million and represented 95% of its revenue. Its enabling technologies segment, which includes ExcelsiusGPS, generated a more modest $40.5 million in sales.\nHowever, the growth opportunities in this area are too enticing to ignore. Analysts project that the market for robot-assisted surgical systems could be worth nearly $18 billion by 2027, growing at a compounded annual growth rate (CAGR) of 14.8% until then.\nWith a solid business today that provides hospitals with important implantable devices plus an exciting growth area related to robotics, Globus can be an investment that provides excellent returns for many years. The healthcare stock has already been picking up steam in the past 12 months, rising more than 70% and outperforming the S&P 500, which is up just 42% during that period.\n2. Microsoft\nTech giant Microsoft is an easy pick for long-term investors. The company provides businesses and individuals with many products and services that will be used for the foreseeable future. Its fastest-growing product is Azure, its cloud computing service where companies can build and test applications. Last quarter, for the first three months of 2021, its year-over-year growth rate was 50% -- highest among the company's segments.\nThe cloud computing market is a high-growth sector to invest in, which could be worth more than $832 billion in 2025. It is already more prevalent than robotic-assisted surgery, but it is still growing at a strong CAGR of 17.5%.\nMicrosoft also has a stable and growing business that is still generating great numbers. Its Office 365 suite, which includes popular programs like Word, Excel, and PowerPoint, grew its commercial sales by 22% in the most recent quarter. And because Office365 is a recurring service, it should be an excellent source of revenue for the company as businesses and individuals renew their licenses.\nNow that companies are spending more time on the cloud, especially as employees look to continue working remotely, investing in businesses that have many attractive cloud-based products and services like Microsoft is a solid move. Shares of the tech stock are up 37% over the past year, and although they have underperformed the S&P 500, investors shouldn't count on that trend lasting over the long term.\n3. DraftKings\nIt has been more than three years since the U.S. Supreme Court lifted the federal ban on sports betting. It is a hot new sector to invest in, and it's only getting bigger as more states choose to legalize it.\nAlthough not everyone has gotten on board with the industry, more than two dozen states now permit some form of sports betting. Globally, the market could be worth $134 billion by 2024 -- growing at a CAGR of close to 10%.\nOne company that is in an excellent position to benefit from that is DraftKings. It entered into an exclusive deal with ESPN last year, which will make DraftKings its \"exclusive daily fantasy sports provider.\" While sports activity has been muted during the pandemic, as the economy gets back to normal and sports leagues are back to operating at or near capacity, it could lead to some stellar results for DraftKings this year.\nWhen the company released its latest results on May 7, it upgraded its guidance and now projects that sales could top $1.15 billion in 2021 (up from a previous forecast that called for no more than $1 billion in revenue). That represents a year-over-year growth rate of 79%.\nSports betting should only become more popular in the years ahead as more states legalize it, leading DraftKings to deliver fantastic returns to investors. Over the past 12 months, the stock has risen by more than 55%, but that jump shouldn't scare away those with a long-term mindset.","news_type":1,"symbols_score_info":{"DKNG":0.9,"GMED":0.9,"MSFT":0.9}},"isVote":1,"tweetType":1,"viewCount":464,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151150196,"gmtCreate":1625068647515,"gmtModify":1633945175102,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151150196","repostId":"1105779613","repostType":4,"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151124402,"gmtCreate":1625068601006,"gmtModify":1633945175817,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151124402","repostId":"1105779613","repostType":4,"isVote":1,"tweetType":1,"viewCount":559,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151122704,"gmtCreate":1625068501508,"gmtModify":1633945177667,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151122704","repostId":"1105779613","repostType":4,"isVote":1,"tweetType":1,"viewCount":388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151126357,"gmtCreate":1625068418579,"gmtModify":1633945178826,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151126357","repostId":"1105779613","repostType":4,"isVote":1,"tweetType":1,"viewCount":547,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":151145335,"gmtCreate":1625069025927,"gmtModify":1633945160746,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"May be","listText":"May be","text":"May be","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151145335","repostId":"1153116027","repostType":4,"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151152720,"gmtCreate":1625068859560,"gmtModify":1633945169564,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151152720","repostId":"2147139718","repostType":4,"repost":{"id":"2147139718","kind":"highlight","pubTimestamp":1625060407,"share":"https://ttm.financial/m/news/2147139718?lang=&edition=full","pubTime":"2021-06-30 21:40","market":"us","language":"en","title":"3 Unstoppable Stocks to Buy and Hold for Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2147139718","media":"Motley Fool","summary":"They are in industries where the annual growth rate is 10% or better.","content":"<p>Buying meme stocks or investing in a company due to a pandemic-related trend can be risky. Investors in these companies can face a lot of volatility, especially as consumer preferences or conditions in the economy change.</p>\n<p>A better way to invest for the long term is by identifying trends that are likely going to continue or even intensify in the future. Robotic-assisted surgery, cloud-based technology, and sports betting are examples of sectors that could provide investors with some terrific growth opportunities for several years. And three companies that would give you exposure to those areas are <b>Globus Medical </b>(NYSE:GMED), <b>Microsoft&nbsp;</b>(NASDAQ:MSFT), and&nbsp;<b>DraftKings&nbsp;</b>(NASDAQ:DKNG).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6dfde80107b5c361f54a6ff94e4e926e\" tg-width=\"700\" tg-height=\"393\"><span>Image source: Getty Images</span></p>\n<h2>1. Globus Medical</h2>\n<p>Globus is a medical device company that makes surgical instruments and implantable devices. It also has an ExcelsiusGPS platform, which is a navigational system for robot-assisted surgery. The company says it is \"the world's first revolutionary robotic navigation platform.\" It specifically helps with alignments of the spine.</p>\n<p>The bulk of the company's revenue today comes from its musculoskeletal segment, which relates to its physical devices; in 2020, sales related to that segment totaled $748 million and represented 95% of its revenue. Its enabling technologies segment, which includes ExcelsiusGPS, generated a more modest $40.5 million in sales.</p>\n<p>However, the growth opportunities in this area are too enticing to ignore. Analysts project that the market for robot-assisted surgical systems could be worth nearly $18 billion by 2027, growing at a compounded annual growth rate (CAGR) of 14.8% until then.</p>\n<p>With a solid business today that provides hospitals with important implantable devices&nbsp;<i>plus</i> an exciting growth area related to robotics, Globus can be an investment that provides excellent returns for many years. The healthcare stock has already been picking up steam in the past 12 months, rising more than 70% and outperforming the&nbsp;<b>S&amp;P 500</b>, which is up just 42% during that period.</p>\n<h2>2. Microsoft</h2>\n<p>Tech giant Microsoft is an easy pick for long-term investors. The company provides businesses and individuals with many products and services that will be used for the foreseeable future. Its fastest-growing product is Azure, its cloud computing service where companies can build and test applications. Last quarter, for the first three months of 2021, its year-over-year growth rate was 50% -- highest among the company's segments.</p>\n<p>The cloud computing market is a high-growth sector to invest in, which could be worth more than $832 billion in 2025. It is already more prevalent than robotic-assisted surgery, but it is still growing at a strong CAGR of 17.5%.</p>\n<p>Microsoft also has a stable and growing business that is still generating great numbers. Its Office 365 suite, which includes popular programs like Word, Excel, and PowerPoint, grew its commercial sales by 22% in the most recent quarter. And because Office365 is a recurring service, it should be an excellent source of revenue for the company as businesses and individuals renew their licenses.</p>\n<p>Now that companies are spending more time on the cloud, especially as employees look to continue working remotely, investing in businesses that have many attractive cloud-based products and services like Microsoft is a solid move. Shares of the tech stock are up 37% over the past year, and although they have underperformed the S&amp;P 500, investors shouldn't count on <i>that </i>trend lasting over the long term.</p>\n<h2>3. DraftKings</h2>\n<p>It has been more than three years since the U.S. Supreme Court lifted the federal ban on sports betting. It is a hot new sector to invest in, and it's only getting bigger as more states choose to legalize it.</p>\n<p>Although not everyone has gotten on board with the industry, more than two dozen states now permit some form of sports betting. Globally, the market could be worth $134 billion by 2024 -- growing at a CAGR of close to 10%.</p>\n<p>One company that is in an excellent position to benefit from that is DraftKings. It entered into an exclusive deal with ESPN last year, which will make DraftKings its \"exclusive daily fantasy sports provider.\" While sports activity has been muted during the pandemic, as the economy gets back to normal and sports leagues are back to operating at or near capacity, it could lead to some stellar results for DraftKings this year.</p>\n<p>When the company released its latest results on May 7, it upgraded its guidance and now projects that sales could top $1.15 billion in 2021 (up from a previous forecast that called for no more than $1 billion in revenue). That represents a year-over-year growth rate of 79%.</p>\n<p>Sports betting should only become more popular in the years ahead as more states legalize it, leading DraftKings to deliver fantastic returns to investors. Over the past 12 months, the stock has risen by more than 55%, but that jump shouldn't scare away those with a long-term mindset.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Unstoppable Stocks to Buy and Hold for Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Unstoppable Stocks to Buy and Hold for Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 21:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/30/3-unstoppable-stocks-to-buy-and-hold-for-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Buying meme stocks or investing in a company due to a pandemic-related trend can be risky. Investors in these companies can face a lot of volatility, especially as consumer preferences or conditions ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/30/3-unstoppable-stocks-to-buy-and-hold-for-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/06/30/3-unstoppable-stocks-to-buy-and-hold-for-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147139718","content_text":"Buying meme stocks or investing in a company due to a pandemic-related trend can be risky. Investors in these companies can face a lot of volatility, especially as consumer preferences or conditions in the economy change.\nA better way to invest for the long term is by identifying trends that are likely going to continue or even intensify in the future. Robotic-assisted surgery, cloud-based technology, and sports betting are examples of sectors that could provide investors with some terrific growth opportunities for several years. And three companies that would give you exposure to those areas are Globus Medical (NYSE:GMED), Microsoft (NASDAQ:MSFT), and DraftKings (NASDAQ:DKNG).\nImage source: Getty Images\n1. Globus Medical\nGlobus is a medical device company that makes surgical instruments and implantable devices. It also has an ExcelsiusGPS platform, which is a navigational system for robot-assisted surgery. The company says it is \"the world's first revolutionary robotic navigation platform.\" It specifically helps with alignments of the spine.\nThe bulk of the company's revenue today comes from its musculoskeletal segment, which relates to its physical devices; in 2020, sales related to that segment totaled $748 million and represented 95% of its revenue. Its enabling technologies segment, which includes ExcelsiusGPS, generated a more modest $40.5 million in sales.\nHowever, the growth opportunities in this area are too enticing to ignore. Analysts project that the market for robot-assisted surgical systems could be worth nearly $18 billion by 2027, growing at a compounded annual growth rate (CAGR) of 14.8% until then.\nWith a solid business today that provides hospitals with important implantable devices plus an exciting growth area related to robotics, Globus can be an investment that provides excellent returns for many years. The healthcare stock has already been picking up steam in the past 12 months, rising more than 70% and outperforming the S&P 500, which is up just 42% during that period.\n2. Microsoft\nTech giant Microsoft is an easy pick for long-term investors. The company provides businesses and individuals with many products and services that will be used for the foreseeable future. Its fastest-growing product is Azure, its cloud computing service where companies can build and test applications. Last quarter, for the first three months of 2021, its year-over-year growth rate was 50% -- highest among the company's segments.\nThe cloud computing market is a high-growth sector to invest in, which could be worth more than $832 billion in 2025. It is already more prevalent than robotic-assisted surgery, but it is still growing at a strong CAGR of 17.5%.\nMicrosoft also has a stable and growing business that is still generating great numbers. Its Office 365 suite, which includes popular programs like Word, Excel, and PowerPoint, grew its commercial sales by 22% in the most recent quarter. And because Office365 is a recurring service, it should be an excellent source of revenue for the company as businesses and individuals renew their licenses.\nNow that companies are spending more time on the cloud, especially as employees look to continue working remotely, investing in businesses that have many attractive cloud-based products and services like Microsoft is a solid move. Shares of the tech stock are up 37% over the past year, and although they have underperformed the S&P 500, investors shouldn't count on that trend lasting over the long term.\n3. DraftKings\nIt has been more than three years since the U.S. Supreme Court lifted the federal ban on sports betting. It is a hot new sector to invest in, and it's only getting bigger as more states choose to legalize it.\nAlthough not everyone has gotten on board with the industry, more than two dozen states now permit some form of sports betting. Globally, the market could be worth $134 billion by 2024 -- growing at a CAGR of close to 10%.\nOne company that is in an excellent position to benefit from that is DraftKings. It entered into an exclusive deal with ESPN last year, which will make DraftKings its \"exclusive daily fantasy sports provider.\" While sports activity has been muted during the pandemic, as the economy gets back to normal and sports leagues are back to operating at or near capacity, it could lead to some stellar results for DraftKings this year.\nWhen the company released its latest results on May 7, it upgraded its guidance and now projects that sales could top $1.15 billion in 2021 (up from a previous forecast that called for no more than $1 billion in revenue). That represents a year-over-year growth rate of 79%.\nSports betting should only become more popular in the years ahead as more states legalize it, leading DraftKings to deliver fantastic returns to investors. Over the past 12 months, the stock has risen by more than 55%, but that jump shouldn't scare away those with a long-term mindset.","news_type":1,"symbols_score_info":{"DKNG":0.9,"GMED":0.9,"MSFT":0.9}},"isVote":1,"tweetType":1,"viewCount":464,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151150196,"gmtCreate":1625068647515,"gmtModify":1633945175102,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151150196","repostId":"1105779613","repostType":4,"isVote":1,"tweetType":1,"viewCount":453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899638695,"gmtCreate":1628177069617,"gmtModify":1633752878078,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899638695","repostId":"2157430168","repostType":4,"repost":{"id":"2157430168","kind":"news","pubTimestamp":1628173962,"share":"https://ttm.financial/m/news/2157430168?lang=&edition=full","pubTime":"2021-08-05 22:32","market":"us","language":"en","title":"Qualcomm tops Magna's bid with $4.6 billion offer for Veoneer","url":"https://stock-news.laohu8.com/highlight/detail?id=2157430168","media":"Reuters","summary":"(Reuters) -Chipmaker Qualcomm Inc said on Thursday it had offered to buy Swedish auto parts maker Ve","content":"<p>(Reuters) -Chipmaker Qualcomm Inc said on Thursday it had offered to buy Swedish auto parts maker Veoneer Inc for $4.6 billion, an 18.4% premium to a bid by Canada's Magna International Inc that was accepted by Veoneer's board.</p>\n<p>U.S.-listed shares of Veoneer rose 21.7% in premarket trading as the stage was set for a bidding war. Neither Magna or Veoneer made any immediate comment.</p>\n<p>Demand has been on the rise for advanced driver assistance systems, known in the industry as ADAS, that add features ranging from collision warning to parking assist. Some systems collect data from cameras and radar to monitor surroundings, interpret the situation and take action.</p>\n<p>Qualcomm, apart from powering mobile phones, has been a chip supplier to carmakers for a decade and last year started its own line of ADAS systems called Snapdragon Ride.</p>\n<p>Earlier this year it signed a signed a collaboration deal with Veoneer to develop a software and chip platform for driver-assistance systems.</p>\n<p>While fully self-driving vehicles are years away, assisted-driving features, such as adaptive cruise control, are being fitted into new cars by most manufacturers.</p>\n<p>Qualcomm hopes to grow its automotive chips business by creating open and competitive platforms for automakers along with Veoneer.</p>\n<p>\"As the automotive industry continues to transform, it is becoming increasingly important for automakers to have a partner who develops horizontal platforms that drive innovation and enable competition,\" said Qualcomm CEO Cristiano Amon.</p>\n<p>Magna has a similar interest in buying Veoneer as it tries to compete with ADAS makers such as Aptiv, Bosch and Continental to capture a larger share of the booming business.</p>\n<p>The Canadian company had offered to buy rival Veoneer in July for about $3.8 billion in cash.</p>\n<p>(Reporting by Chavi Mehta in Bengaluru and Supantha Mukherjee in Stockholm; Editing by Krishna Chandra Eluri, Vinay Dwivedi, Elaine Hardcastle)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qualcomm tops Magna's bid with $4.6 billion offer for Veoneer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQualcomm tops Magna's bid with $4.6 billion offer for Veoneer\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-05 22:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/qualcomm-offers-buy-automotive-tech-131242676.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -Chipmaker Qualcomm Inc said on Thursday it had offered to buy Swedish auto parts maker Veoneer Inc for $4.6 billion, an 18.4% premium to a bid by Canada's Magna International Inc that was ...</p>\n\n<a href=\"https://finance.yahoo.com/news/qualcomm-offers-buy-automotive-tech-131242676.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VNE":"Veoneer, Inc.","QCOM":"高通"},"source_url":"https://finance.yahoo.com/news/qualcomm-offers-buy-automotive-tech-131242676.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2157430168","content_text":"(Reuters) -Chipmaker Qualcomm Inc said on Thursday it had offered to buy Swedish auto parts maker Veoneer Inc for $4.6 billion, an 18.4% premium to a bid by Canada's Magna International Inc that was accepted by Veoneer's board.\nU.S.-listed shares of Veoneer rose 21.7% in premarket trading as the stage was set for a bidding war. Neither Magna or Veoneer made any immediate comment.\nDemand has been on the rise for advanced driver assistance systems, known in the industry as ADAS, that add features ranging from collision warning to parking assist. Some systems collect data from cameras and radar to monitor surroundings, interpret the situation and take action.\nQualcomm, apart from powering mobile phones, has been a chip supplier to carmakers for a decade and last year started its own line of ADAS systems called Snapdragon Ride.\nEarlier this year it signed a signed a collaboration deal with Veoneer to develop a software and chip platform for driver-assistance systems.\nWhile fully self-driving vehicles are years away, assisted-driving features, such as adaptive cruise control, are being fitted into new cars by most manufacturers.\nQualcomm hopes to grow its automotive chips business by creating open and competitive platforms for automakers along with Veoneer.\n\"As the automotive industry continues to transform, it is becoming increasingly important for automakers to have a partner who develops horizontal platforms that drive innovation and enable competition,\" said Qualcomm CEO Cristiano Amon.\nMagna has a similar interest in buying Veoneer as it tries to compete with ADAS makers such as Aptiv, Bosch and Continental to capture a larger share of the booming business.\nThe Canadian company had offered to buy rival Veoneer in July for about $3.8 billion in cash.\n(Reporting by Chavi Mehta in Bengaluru and Supantha Mukherjee in Stockholm; Editing by Krishna Chandra Eluri, Vinay Dwivedi, Elaine Hardcastle)","news_type":1,"symbols_score_info":{"QCOM":0.9,"VNE":0.9}},"isVote":1,"tweetType":1,"viewCount":418,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151179304,"gmtCreate":1625069133708,"gmtModify":1633945156958,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Be careful","listText":"Be careful","text":"Be careful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151179304","repostId":"2147585034","repostType":4,"repost":{"id":"2147585034","kind":"highlight","pubTimestamp":1625024760,"share":"https://ttm.financial/m/news/2147585034?lang=&edition=full","pubTime":"2021-06-30 11:46","market":"us","language":"en","title":"This Hot Reddit Stock Just Gave Investors an Ominous Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2147585034","media":"Motley Fool","summary":"It's a warning that investors should take seriously.","content":"<p>This year was shaping up to be a miserable <a href=\"https://laohu8.com/S/AONE\">one</a> for&nbsp;<b>Clover Health</b> (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's shares have soared in recent weeks.</p>\n<p>Don't think that the waters are safe to jump aboard the bandwagon for Clover Health yet, however.&nbsp;Here's why this hot Reddit stock just gave investors an ominous warning.</p>\n<h2>Brutal honesty</h2>\n<p>All publicly traded companies want investors to buy their shares. Buying tends to beget more buying, which pushes the stock price up. It's rare that any company warns investors not to buy its stock. But that's exactly what Clover Health did recently.</p>\n<p>Companies that plan to issue additional shares file a prospectus with the U.S. Securities and Exchange Commission (SEC). This prospectus gives potential investors a lot of information about the business and lays out the key reasons why they might want to buy the new shares.</p>\n<p>Clover Health filed such a prospectus earlier this year, outlining its intent to issue additional Class B shares. These shares don't have the same level of voting rights as its Class A shares. Last week, the company submitted an amendment to the SEC for this prospectus. And that amendment contained a brutally honest message for potential investors.</p>\n<p>The company acknowledged that its recent gains could be due to a short squeeze. Because of the potential for an additional short squeeze and its aftermath, Clover Health gave an unusually stark warning to investors: \"Under the circumstances, we caution you against investing in our Class B common stock, unless you are prepared to incur the risk of losing all or a substantial portion of your investment.\" It also noted, \"Investors that purchase shares of our Class A common stock during a short squeeze may lose a significant portion of their investment.\"</p>\n<h2>No fear?</h2>\n<p>Clover Health explained clearly what could happen with both its Class A and Class B shares. The company stated that if another short squeeze happens, once short-sellers cover their positions or if investors otherwise think the short squeeze has run its course, its stock price could fall quickly.</p>\n<p>You might think that such an ominous warning would scare off many investors. Nope. Instead, it produced an opposite effect. Last week, shares of Clover Health soared by a double-digit percentage immediately after the company's amended prospectus with the serious warning was submitted to the SEC.</p>\n<p>This reaction might seem counterintuitive. After all, Clover Health informed investors in no uncertain terms about the risks they face with buying the stock. So why did the shares of the company surge instead of sink? I think there are different reasons for different investors.</p>\n<p>Some truly believe in Clover Health and are willing to hold onto the stock regardless of what happens over the short term. Others are fully aware that the gains generated by a short squeeze could evaporate quickly but think they'll be able to sell in time to still make a big profit. Unfortunately, there could also be some who are new to investing and didn't pay attention to or didn't understand Clover Health's cautionary message.</p>\n<h2>Business vs. stock</h2>\n<p>It's always wise to think of buying a stock as buying a part of a business. That's exactly what you're doing when you buy shares of Clover Health or any other company. When the underlying business is strong and has great prospects, you don't have to be concerned about short-term volatility with the share price.</p>\n<p>However, there are times when share prices get way out of alignment with the prospects of the underlying business. Short squeezes can often make this happen. In these cases, it's especially important to be careful in buying a stock. Sure, you're still buying a part of a business -- but you can pay a lot more than the business is actually worth.</p>\n<p>In my view, there are several reasons to like Clover Health's underlying business. The company has an intriguing technology that physicians use. It's expanding into the original Medicare market, a move that could boost sales tremendously. Clover Health has a visionary management team.</p>\n<p>But buying a stock that's a short squeeze candidate is risky if you aren't ready, willing, and able to sell shares immediately once the short squeeze ends. When a company issues a warning like Clover Health just did, the smart thing to do is to listen and take that warning seriously.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Hot Reddit Stock Just Gave Investors an Ominous Warning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Hot Reddit Stock Just Gave Investors an Ominous Warning\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 11:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This year was shaping up to be a miserable one for Clover Health (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp"},"source_url":"https://www.fool.com/investing/2021/06/29/this-hot-reddit-stock-just-gave-investors-an-omino/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147585034","content_text":"This year was shaping up to be a miserable one for Clover Health (NASDAQ:CLOV). Note the use of the past tense in that statement, though. Thanks in large part to Reddit users piling on, Clover's shares have soared in recent weeks.\nDon't think that the waters are safe to jump aboard the bandwagon for Clover Health yet, however. Here's why this hot Reddit stock just gave investors an ominous warning.\nBrutal honesty\nAll publicly traded companies want investors to buy their shares. Buying tends to beget more buying, which pushes the stock price up. It's rare that any company warns investors not to buy its stock. But that's exactly what Clover Health did recently.\nCompanies that plan to issue additional shares file a prospectus with the U.S. Securities and Exchange Commission (SEC). This prospectus gives potential investors a lot of information about the business and lays out the key reasons why they might want to buy the new shares.\nClover Health filed such a prospectus earlier this year, outlining its intent to issue additional Class B shares. These shares don't have the same level of voting rights as its Class A shares. Last week, the company submitted an amendment to the SEC for this prospectus. And that amendment contained a brutally honest message for potential investors.\nThe company acknowledged that its recent gains could be due to a short squeeze. Because of the potential for an additional short squeeze and its aftermath, Clover Health gave an unusually stark warning to investors: \"Under the circumstances, we caution you against investing in our Class B common stock, unless you are prepared to incur the risk of losing all or a substantial portion of your investment.\" It also noted, \"Investors that purchase shares of our Class A common stock during a short squeeze may lose a significant portion of their investment.\"\nNo fear?\nClover Health explained clearly what could happen with both its Class A and Class B shares. The company stated that if another short squeeze happens, once short-sellers cover their positions or if investors otherwise think the short squeeze has run its course, its stock price could fall quickly.\nYou might think that such an ominous warning would scare off many investors. Nope. Instead, it produced an opposite effect. Last week, shares of Clover Health soared by a double-digit percentage immediately after the company's amended prospectus with the serious warning was submitted to the SEC.\nThis reaction might seem counterintuitive. After all, Clover Health informed investors in no uncertain terms about the risks they face with buying the stock. So why did the shares of the company surge instead of sink? I think there are different reasons for different investors.\nSome truly believe in Clover Health and are willing to hold onto the stock regardless of what happens over the short term. Others are fully aware that the gains generated by a short squeeze could evaporate quickly but think they'll be able to sell in time to still make a big profit. Unfortunately, there could also be some who are new to investing and didn't pay attention to or didn't understand Clover Health's cautionary message.\nBusiness vs. stock\nIt's always wise to think of buying a stock as buying a part of a business. That's exactly what you're doing when you buy shares of Clover Health or any other company. When the underlying business is strong and has great prospects, you don't have to be concerned about short-term volatility with the share price.\nHowever, there are times when share prices get way out of alignment with the prospects of the underlying business. Short squeezes can often make this happen. In these cases, it's especially important to be careful in buying a stock. Sure, you're still buying a part of a business -- but you can pay a lot more than the business is actually worth.\nIn my view, there are several reasons to like Clover Health's underlying business. The company has an intriguing technology that physicians use. It's expanding into the original Medicare market, a move that could boost sales tremendously. Clover Health has a visionary management team.\nBut buying a stock that's a short squeeze candidate is risky if you aren't ready, willing, and able to sell shares immediately once the short squeeze ends. When a company issues a warning like Clover Health just did, the smart thing to do is to listen and take that warning seriously.","news_type":1,"symbols_score_info":{"CLOV":0.9,"JE":0.9}},"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151124402,"gmtCreate":1625068601006,"gmtModify":1633945175817,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151124402","repostId":"1105779613","repostType":4,"isVote":1,"tweetType":1,"viewCount":559,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151122704,"gmtCreate":1625068501508,"gmtModify":1633945177667,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151122704","repostId":"1105779613","repostType":4,"isVote":1,"tweetType":1,"viewCount":388,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151126357,"gmtCreate":1625068418579,"gmtModify":1633945178826,"author":{"id":"4088084941946900","authorId":"4088084941946900","name":"KKK123","avatar":"https://static.tigerbbs.com/2578fc589c17773b27b58cfa82161ef7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088084941946900","authorIdStr":"4088084941946900"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/151126357","repostId":"1105779613","repostType":4,"isVote":1,"tweetType":1,"viewCount":547,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}